Viemed Healthcare (VMD) Total Non-Current Liabilities (2018 - 2026)
Viemed Healthcare (VMD) posted Total Non-Current Liabilities of $10.9 million for Q1 2026, down 25.51% on a QoQ basis from $14.6 million in Q4 2025, and up 85.85% year-over-year from $5.8 million in Q1 2025.
Viemed Healthcare (VMD) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
Viemed Healthcare's Total Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $10.9 million for Q1 2026.
- Quarterly Total Non-Current Liabilities rose 85.85% year-over-year to $10.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.9 million (up 85.85% YoY) and the FY2025 annual result came in at $14.6 million, up 126.28% from the prior year.
- Total Non-Current Liabilities was $10.9 million for Q1 2026 at Viemed Healthcare, down from $14.6 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $22.7 million in Q3 2025 and bottomed at $1.1 million in Q4 2022.
- A 5-year average of $8.3 million and a median of $6.4 million in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities tumbled 79.59% — and 2023, when it jumped 715.81%.
- Viemed Healthcare's Total Non-Current Liabilities stood at $1.1 million in 2022, then soared by 715.81% to $8.9 million in 2023, then slipped by 27.42% to $6.4 million in 2024, then jumped by 126.28% to $14.6 million in 2025, then retreated by 25.51% to $10.9 million in 2026.
- Business Quant data shows VMD's Total Non-Current Liabilities at $10.9 million in Q1 2026, $14.6 million in Q4 2025, and $22.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Viemed Healthcare | 448.46 Mn | 440.63 Mn | 42.83 Mn | 10.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.86 Mn |
| Dec 31, 2025 | 14.58 Mn |
| Sep 30, 2025 | 22.68 Mn |
| Jun 30, 2025 | 5.71 Mn |
| Mar 31, 2025 | 5.84 Mn |
| Dec 31, 2024 | 6.44 Mn |
| Sep 30, 2024 | 6.29 Mn |
| Jun 30, 2024 | 11.29 Mn |
| Mar 31, 2024 | 8.49 Mn |
| Dec 31, 2023 | 8.88 Mn |
| Sep 30, 2023 | 9.03 Mn |
| Jun 30, 2023 | 13.04 Mn |
| Mar 31, 2023 | 1.17 Mn |
| Dec 31, 2022 | 1.09 Mn |
| Sep 30, 2022 | 4.95 Mn |
| Jun 30, 2022 | 4.82 Mn |
| Mar 31, 2022 | 5.23 Mn |
| Dec 31, 2021 | 5.33 Mn |
| Sep 30, 2021 | 5.91 Mn |
| Jun 30, 2021 | 6.43 Mn |